DE60142749D1 - Benzoylpyridazine - Google Patents

Benzoylpyridazine

Info

Publication number: DE60142749D1
Authority: DE; Germany
Prior art keywords: benzoylpyridazine
Prior art date: 2000-12-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60142749T

Other languages

English (en)

Inventor

Hans-Michael Eggenweiler

Michael Wolf

Norbert Beier

Joachim Leibrock

Michael Gassen

Thomas Ehring

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-23

Filing date

2001-12-19

Publication date

2010-09-16

2001-12-19 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

2001-12-19 Priority to DE60142749T priority Critical patent/DE60142749D1/de

2010-09-16 Application granted granted Critical

2010-09-16 Publication of DE60142749D1 publication Critical patent/DE60142749D1/de

2021-12-20 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Oncology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Endocrinology (AREA)
Otolaryngology (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)

DE60142749T 2000-12-23 2001-12-19 Benzoylpyridazine Expired - Lifetime DE60142749D1 (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DE60142749T DE60142749D1 (de)	2000-12-23	2001-12-19	Benzoylpyridazine

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10064997A DE10064997A1 (de)	2000-12-23	2000-12-23	Benzoylpyridazine
DE60142749T DE60142749D1 (de)	2000-12-23	2001-12-19	Benzoylpyridazine
PCT/EP2001/015070 WO2002051814A1 (en)	2000-12-23	2001-12-19	Benzoylpyridazines

Publications (1)

Publication Number	Publication Date
DE60142749D1 true DE60142749D1 (de)	2010-09-16

Family

ID=7668970

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE10064997A Withdrawn DE10064997A1 (de)	2000-12-23	2000-12-23	Benzoylpyridazine
DE60142749T Expired - Lifetime DE60142749D1 (de)	2000-12-23	2001-12-19	Benzoylpyridazine

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE10064997A Withdrawn DE10064997A1 (de)	2000-12-23	2000-12-23	Benzoylpyridazine

Country Status (20)

Country	Link
US (1)	US7312328B2 (de)
EP (1)	EP1343769B1 (de)
JP (1)	JP4532071B2 (de)
KR (1)	KR20030065564A (de)
CN (1)	CN1483026A (de)
AR (1)	AR032010A1 (de)
AT (1)	ATE476423T1 (de)
BR (1)	BR0116304A (de)
CA (1)	CA2432568C (de)
CZ (1)	CZ20031860A3 (de)
DE (2)	DE10064997A1 (de)
ES (1)	ES2349622T3 (de)
HU (1)	HUP0302562A2 (de)
MX (1)	MXPA03005494A (de)
NO (1)	NO20032862D0 (de)
PL (1)	PL364229A1 (de)
RU (1)	RU2003122188A (de)
SK (1)	SK8662003A3 (de)
WO (1)	WO2002051814A1 (de)
ZA (1)	ZA200305661B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003300076C1 (en)	2002-12-30	2010-03-04	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
PE20060272A1 (es) *	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
WO2010135468A1 (en) *	2009-05-19	2010-11-25	Vivia Biotech S.L.	Methods for providing personalized medicine tests ex vivo for hematological neoplasms
US10806711B2 (en)	2011-08-12	2020-10-20	University Of Cincinnati	Method of treating acute decompensated heart failure with probenecid
US10583103B2 (en)	2013-03-13	2020-03-10	University Of Cincinnati	Method of treating heart failure with preserved ejection fraction with probenecid
US10500178B2 (en)	2015-03-13	2019-12-10	The Board Of Trustees Of The Leland Stanford Junior University	LTB4 inhibition to prevent and treat human lymphedema
CN105175283A (zh) *	2015-09-23	2015-12-23	蚌埠中实化学技术有限公司	一种3-乙氧基-4-甲氧基苯腈的制备方法
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ254534A (en) *	1992-07-01	1997-12-19	Ortho Pharma Corp	1,4,5,6-tetrahydro-pyridazine derivatives, preparation and pharmaceutical compositions thereof
JP3806144B2 (ja)	1993-12-22	2006-08-09	セルテックセラピューティックスリミテッド	三置換フェニル誘導体、その調製方法とホスホジエステラーゼ（ｉｖ型）阻害剤としてのその使用
US5786354A (en)	1994-06-21	1998-07-28	Celltech Therapeutics, Limited	Tri-substituted phenyl derivatives and processes for their preparation
GB9412672D0 (en)	1994-06-23	1994-08-10	Celltech Ltd	Chemical compounds
DE19514568A1 (de) *	1995-04-20	1996-10-24	Merck Patent Gmbh	Arylalkyl-pyridazinone
DE19533975A1 (de) *	1995-09-14	1997-03-20	Merck Patent Gmbh	Arylalkyl-diazinone
GB9525262D0 (en)	1995-12-11	1996-02-07	Bayer Ag	Heterocyclylcarbonyl substituted benzofuranyl-ureas
DE19632549A1 (de) *	1996-08-13	1998-02-19	Merck Patent Gmbh	Arylalkanoylpyridazine
DE19826841A1 (de) *	1998-06-16	1999-12-23	Merck Patent Gmbh	Arylalkanoylpyridazine
DE19850701A1 (de) *	1998-11-04	2000-05-11	Merck Patent Gmbh	Benzoylpyridazine

2000
- 2000-12-23 DE DE10064997A patent/DE10064997A1/de not_active Withdrawn
2001
- 2001-12-19 JP JP2002552911A patent/JP4532071B2/ja not_active Expired - Fee Related
- 2001-12-19 CZ CZ20031860A patent/CZ20031860A3/cs unknown
- 2001-12-19 US US10/451,393 patent/US7312328B2/en not_active Expired - Fee Related
- 2001-12-19 KR KR10-2003-7008423A patent/KR20030065564A/ko not_active Withdrawn
- 2001-12-19 AR ARP010105890A patent/AR032010A1/es unknown
- 2001-12-19 CN CNA018211763A patent/CN1483026A/zh active Pending
- 2001-12-19 RU RU2003122188/04A patent/RU2003122188A/ru not_active Application Discontinuation
- 2001-12-19 MX MXPA03005494A patent/MXPA03005494A/es unknown
- 2001-12-19 BR BR0116304-3A patent/BR0116304A/pt not_active Application Discontinuation
- 2001-12-19 WO PCT/EP2001/015070 patent/WO2002051814A1/en not_active Ceased
- 2001-12-19 PL PL01364229A patent/PL364229A1/xx unknown
- 2001-12-19 EP EP01272031A patent/EP1343769B1/de not_active Expired - Lifetime
- 2001-12-19 AT AT01272031T patent/ATE476423T1/de not_active IP Right Cessation
- 2001-12-19 CA CA2432568A patent/CA2432568C/en not_active Expired - Fee Related
- 2001-12-19 DE DE60142749T patent/DE60142749D1/de not_active Expired - Lifetime
- 2001-12-19 ES ES01272031T patent/ES2349622T3/es not_active Expired - Lifetime
- 2001-12-19 SK SK866-2003A patent/SK8662003A3/sk unknown
- 2001-12-19 HU HU0302562A patent/HUP0302562A2/hu unknown
2003
- 2003-06-20 NO NO20032862A patent/NO20032862D0/no not_active Application Discontinuation
- 2003-07-22 ZA ZA200305661A patent/ZA200305661B/en unknown

Also Published As

Publication number	Publication date
HUP0302562A2 (hu)	2003-11-28
JP4532071B2 (ja)	2010-08-25
JP2004519450A (ja)	2004-07-02
DE10064997A1 (de)	2002-06-27
ATE476423T1 (de)	2010-08-15
CN1483026A (zh)	2004-03-17
US7312328B2 (en)	2007-12-25
MXPA03005494A (es)	2003-10-06
PL364229A1 (en)	2004-12-13
US20040067954A1 (en)	2004-04-08
BR0116304A (pt)	2003-09-30
CZ20031860A3 (cs)	2003-10-15
ES2349622T3 (es)	2011-01-07
KR20030065564A (ko)	2003-08-06
CA2432568A1 (en)	2002-07-04
CA2432568C (en)	2011-08-09
NO20032862L (no)	2003-06-20
SK8662003A3 (en)	2003-12-02
WO2002051814A1 (en)	2002-07-04
EP1343769A1 (de)	2003-09-17
RU2003122188A (ru)	2005-02-27
NO20032862D0 (no)	2003-06-20
EP1343769B1 (de)	2010-08-04
ZA200305661B (en)	2004-10-22
AR032010A1 (es)	2003-10-22

Publication	Publication Date	Title
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
DE50106867D1 (de)	2005-09-01	Kugelgelenk
DE50102988D1 (de)	2004-09-02	Bodenwischer
DE50100710D1 (de)	2003-11-06	Wischblatt
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
DE50104651D1 (de)	2005-01-05	Fahrzeugfaltverdeck
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
ATE284887T1 (de)	2005-01-15	Thienopyrrolidinone
DE50103443D1 (de)	2004-10-07	Doppelwandbohrrohr
DE10054120B4 (de)	2005-10-20	Aufsparrendämmelement
DE50010192D1 (de)	2005-06-02	Intaglio-druckmaschine
ATA7092001A (de)	2004-08-15	Skibindungseinstellgerät